Loading Please Wait
Call Toll Free:
877-985-2695
Sign in
|
Join
|
Help
SEARCH:
Home
Products
Articles
Health Blog
Pets
Fitness
Videos
My Clinic
Contact Us
The World's #1 Natural Health Website
†
Loading Please Wait
INVITE YOUR FRIENDS
Import Email Addresses from almost any email service to invite your friends.
Article Tools
Print this Page
Save as Favorites
My Saved Articles
Current Newsletter
Share Your Comment
Podcasts
Submit My Story
Newsletter Feed
Health Blog Feed
BROWSE BY
TAGS
Aging
Allergies
Alzheimers
Arthritis
Aspartame
Asthma
Autism
Back Pain
Brain Health
Cancer
Children's Health
Cholesterol
Cold and Flu
Depression
Detoxification
Diabetes
Digestive Diseases
Digestive Health
Drug Industry
Drugs
EMF
Emotional Health
Entertainment
Fatigue
Fibromyalgia
Finances
Fitness/Exercise
Fluoride
Food
Fructose/Sugar
Gardening
GMO
Heart Disease
Heart Health
High Blood Pressure
Hormones
Immune Support
Joint Support
Juicing
Kids Video
Men's Health
Mercury Free Dentistry
Nutritional Typing
Obesity
Osteoporosis
Pet Videos
Pets
Politics
Raw Milk
Sexual Health
Sleep
Soy
Statins
Supplements
Technology
Thyroid Disease
Vaccines
Vision Health
Vitamin D
Water
Weight Management
Women's Health
TRANSLATE THIS PAGE:
Invite Your Friends
Invite Your Friends
Swine Flu is a Windfall for Drugmakers
Posted By
Dr. Mercola
|
September 28 2009 |
3,245
views
Tweet
Email
Previous
Next
Email this article to a friend
Five biopharmaceutical companies have been awarded massive contracts by the U.S. Department of Health and Human Services (HHS) for development and production of more than 195 million doses of swine flu vaccine.
The companies -- Novartis, GlaxoSmithKline, MedImmune, Australian drug maker CSL, and Sanofi-Pasteur -- will likely make a great deal of money.
CSL has contracts to supply $180 million worth of bulk antigen to the U.S. MedImmune will supply 40 million doses of its live attenuated nasal spray swine flu vaccine for more than $450 million. Sanofi-Pasteur is providing more than 100 million doses of monovalent swine flu vaccine, a $690 million order.
Sources:
The Scientist September 23, 2009
Tweet
Email
Previous Article
Next Article
Loading Please Wait
View Comments (5)
POST YOUR COMMENT
Reply to this thread
(2000 Characters only.)
Characters remaining:
* Please enter your comment!
Edit Your Comment
(2000 Characters only.)
Characters remaining:
* Please enter your comment!
Comment deleted violating the aspect of our terms of use
Tweet
Email
Previous Article
Next Article
Please
or
to continue
.
Save Options
Private Favorites
(This will appear on your saved articles for later viewing)
Shared Favorites
(This will appear on your profile as one of your favorites)
Invite Your Friends
Invite Your Friends